SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-12-002304
Filing Date
2012-10-25
Accepted
2012-10-25 16:51:31
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 medizone10q093012.htm 10-Q 492109
2 ex31-1.htm EX-31.1 10200
3 ex31-2.htm EX-31.2 9987
4 ex32-1.htm EX-32.1 4640
5 ex32-2.htm EX-32.2 4274
  Complete submission text file 0001185185-12-002304.txt   2962210

Data Files

Seq Description Document Type Size
6 mzei-20120930.xml EX-101.INS 318145
7 mzei-20120930.xsd EX-101.SCH 38903
8 mzei-20120930_cal.xml EX-101.CAL 29972
9 mzei-20120930_def.xml EX-101.DEF 169072
10 mzei-20120930_lab.xml EX-101.LAB 253003
11 mzei-20120930_pre.xml EX-101.PRE 173588
Mailing Address 4000 BRIDGEWAY SUITE 401 SAUSALITO CA 94965
Business Address 4000 BRIDGEWAY SUITE 401 SAUSALITO CA 94965 (415) 331-0303
MEDIZONE INTERNATIONAL INC (Filer) CIK: 0000753772 (see all company filings)

IRS No.: 870412648 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 002-93277-D | Film No.: 121162067
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries